Pet Safety / Compounds / Venlafaxine (Effexor)

Is Venlafaxine (Effexor) safe for dogs and cats?

Elevated risk for pets

Venlafaxine is considered one of the more dangerous human antidepressants for dogs — the dual serotonergic and noradrenergic mechanism causes more severe and complex toxicity than pure SSRIs, and venlafaxine-toxic dogs frequently require intensive care. Toxic dose: ASPCA APCC data indicate clinical signs in dogs at ≥1.8 mg/kg; moderate-severe signs at 5–10 mg/kg; life-threatening toxicity possible at >10 mg/kg, particularly with XR formulation. Extended-release pellets: Effexor XR capsules contain extended-release pellets; dogs may vomit intact pellets initially, then reabsorb in the GI tract — clinical signs can be delayed and prolonged compared to immediate-release ingestion. Signs: serotonin syndrome (tremors, hyperthermia, mydriasis, hyperreflexia), tachycardia, hypertension (NE component), agitation, seizures; cardiac arrhythmias reported at high doses. Honey-like odor: venlafaxine capsule contents have a distinctive odor that makes them appealing to dogs — frequently ingested even when fallen on the floor. Treatment: aggressive decontamination if early; cyproheptadine; methocarbamol; antihypertensives if significant hypertension (prazosin); benzodiazepines for seizures; IV fluids; extended monitoring (12–24 hours for XR). Fatalities: case reports of canine fatalities from venlafaxine ingestion exist; prompt veterinary care is critical.

What is venlafaxine (effexor)?

The IUPAC name is 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol.

Also known as: 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol, venlafaxine, Elafax, Venlafaxina.

IUPAC name
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol
CAS number
93413-69-5
Molecular formula
C17H27NO2
Molecular weight
277.4 g/mol
SMILES
CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
PubChem CID
5656

Risk for dogs

Elevated risk

Venlafaxine is considered one of the more dangerous human antidepressants for dogs — the dual serotonergic and noradrenergic mechanism causes more severe and complex toxicity than pure SSRIs, and venlafaxine-toxic dogs frequently require intensive care. Toxic dose: ASPCA APCC data indicate clinical signs in dogs at ≥1.8 mg/kg; moderate-severe signs at 5–10 mg/kg; life-threatening toxicity possible at >10 mg/kg, particularly with XR formulation. Extended-release pellets: Effexor XR capsules contain extended-release pellets; dogs may vomit intact pellets initially, then reabsorb in the GI tract — clinical signs can be delayed and prolonged compared to immediate-release ingestion. Signs: serotonin syndrome (tremors, hyperthermia, mydriasis, hyperreflexia), tachycardia, hypertension (NE component), agitation, seizures; cardiac arrhythmias reported at high doses. Honey-like odor: venlafaxine capsule contents have a distinctive odor that makes them appealing to dogs — frequently ingested even when fallen on the floor. Treatment: aggressive decontamination if early; cyproheptadine; methocarbamol; antihypertensives if significant hypertension (prazosin); benzodiazepines for seizures; IV fluids; extended monitoring (12–24 hours for XR). Fatalities: case reports of canine fatalities from venlafaxine ingestion exist; prompt veterinary care is critical.

Regulatory consensus

1 regulatory bodyhas classified Venlafaxine (Effexor).

AgencyYearClassificationNotes
FDA—Approved for MDD, GAD, SAD, and panic disorder

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where pets encounter venlafaxine (effexor)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Venlafaxine (Effexor):

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is venlafaxine (effexor) safe for pets?

Venlafaxine is considered one of the more dangerous human antidepressants for dogs — the dual serotonergic and noradrenergic mechanism causes more severe and complex toxicity than pure SSRIs, and venlafaxine-toxic dogs frequently require intensive care. Toxic dose: ASPCA APCC data indicate clinical signs in dogs at ≥1.8 mg/kg; moderate-severe signs at 5–10 mg/kg; life-threatening toxicity possible at >10 mg/kg, particularly with XR formulation. Extended-release pellets: Effexor XR capsules contain extended-release pellets; dogs may vomit intact pellets initially, then reabsorb in the GI tract — clinical signs can be delayed and prolonged compared to immediate-release ingestion. Signs: serotonin syndrome (tremors, hyperthermia, mydriasis, hyperreflexia), tachycardia, hypertension (NE component), agitation, seizures; cardiac arrhythmias reported at high doses. Honey-like odor: venlafaxine capsule contents have a distinctive odor that makes them appealing to dogs — frequently ingested even when fallen on the floor. Treatment: aggressive decontamination if early; cyproheptadine; methocarbamol; antihypertensives if significant hypertension (prazosin); benzodiazepines for seizures; IV fluids; extended monitoring (12–24 hours for XR). Fatalities: case reports of canine fatalities from venlafaxine ingestion exist; prompt veterinary care is critical.

What products contain venlafaxine (effexor)?

Venlafaxine (Effexor) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

See Venlafaxine (Effexor) in the pets app

Look up products containing venlafaxine (effexor), compare to alternatives, and explore the full data record.

Open in pets View raw API data

Sources (2)
  1. FDA Prescribing Information: Venlafaxine (Effexor XR) — MDD/GAD/SAD/panic; SNRI; blood pressure monitoring; overdose fatality risk; discontinuation syndrome; negative pediatric trials; CYP2D6 to desvenlafaxine; MAOI contraindication (2023) (2023) — regulatory
  2. ASPCA Animal Poison Control Center: SNRI Toxicosis in Dogs — venlafaxine extended-release pellets; dual serotonin/norepinephrine toxidrome; toxic dose thresholds; cardiac effects; intensive care management; fatality risk (2023) (2023) — veterinary

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →